0001214659-22-003676.txt : 20220307
0001214659-22-003676.hdr.sgml : 20220307
20220307163526
ACCESSION NUMBER: 0001214659-22-003676
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220303
FILED AS OF DATE: 20220307
DATE AS OF CHANGE: 20220307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THORBURN JAMES M
CENTRAL INDEX KEY: 0001252038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 22718567
MAIL ADDRESS:
STREET 1: C/O ZILOG INC
STREET 2: 532 RACE STREET
CITY: SAN JOSE
STATE: CA
ZIP: 95126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-55689.xml
PRIMARY DOCUMENT
X0306
4
2022-03-03
0001581280
Twist Bioscience Corp
TWST
0001252038
THORBURN JAMES M
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Financial Officer
Common Stock
2022-03-03
4
M
false
1517
26.66
A
48662
D
Common Stock
2022-03-03
4
M
false
2000
23.33
A
50662
D
Common Stock
2022-03-03
4
S
false
2107
51.9646
D
48555
D
Common Stock
2022-03-03
4
S
false
1230
52.8060
D
47325
D
Common Stock
2022-03-03
4
S
false
180
53.68
D
47145
D
Employee Stock Option (right to buy)
26.66
2022-03-03
4
M
false
1517
0
D
2028-11-18
Common Stock
1517
40381
D
Employee Stock Option (right to buy)
23.33
2022-03-03
4
M
false
2000
0
D
2029-10-23
Common Stock
2000
25748
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
Represents the weighted average sales price per share. The shares sold at prices ranging from $51.46 to $52.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $52.47 to $53.35 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)
20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for James M. Thorburn
2022-03-07